U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07939139) titled 'Shadow-Mode Evaluation of an AI Assistant for Multidisciplinary Tumor Boards' on Nov. 09.

Brief Summary: This study tests whether an artificial intelligence (AI) system that drafts tumor board recommendations performs as well on new cases as it did on archived cases. The system runs in shadow mode at three multidisciplinary tumor boards of TUM University Hospital rechts der Isar. For each case it drafts a recommendation before the board meets. The board does not see the draft, and the draft has no influence on patient care. After the meeting, each draft is compared with the board decision. The agreement rate is then compared with th...